Randomized Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)

The purpose of this study is to evaluate the tolerability, safety and efficacy of 3-step
titration versus 1-step titration of Rivastigmine patch in the Japanese population.

Clinical Trial Conditions: Alzheimer's Disease

Treatments in this Clinical Trial : Active Comparator, ENA713

Clinical Trial Phase: Phase 3

Eligible Clinical Trial Participant Age : Between 50 years to 85 years

Can Healthy Volunteers Participate: No

Clinical Trial Lead Sponsor: Novartis Pharmaceuticals

Detailed Clinical Trial Description: The purpose of this study is to evaluate the tolerability, safety and efficacy of 3-step
titration versus 1-step titration of Rivastigmine patch in the Japanese population.

The clinical trial information was obtained from http://clinicaltrials.gov/ct2/show/NCT01614886